THORACIC EPIDURAL ANALGESICS PROVIDE EXCELLENT CANCER PAIN RELIEF AT THE END OF LIFE

Paul A. Sloan, MD

doi:10.5055/jom.2010.0105

THORACIC EPIDURAL ANALGESICS PROVIDE EXCELLENT CANCER PAIN RELIEF AT THE END OF LIFE

Authors

Paul A. Sloan, MD

DOI:

https://doi.org/10.5055/jom.2010.0105

Keywords:

Abstract

Author Biography

Paul A. Sloan, MD

Department of Anesthesiology University of Kentucky, Lexington, Kentucky

References

Sloan PA: Neuraxial pain relief for intractable cancer pain. Curr Pain Headache Rep. 2007; 11: 283-289.

Sloan PA: The evolving role of interventional pain management in oncology. J Support Oncol. 2004; 2: 491-506.

Sloan PA, Hodes J, John W: Radiosurgical pituitary ablation for cancer pain. J Palliat Care. 1996; 12: 51-53.

Mercadante S, Intravaia G, Villari P, et al.: Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain. 2007; 23: 793-798.

Flack SH, Bernards CM: Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs. Anesthesiology. 2010; 112: 165-173.

Downloads

Published

01/29/2018

How to Cite

Sloan, MD, P. A. “THORACIC EPIDURAL ANALGESICS PROVIDE EXCELLENT CANCER PAIN RELIEF AT THE END OF LIFE”. Journal of Opioid Management, vol. 6, no. 3, Jan. 2018, p. 161, doi:10.5055/jom.2010.0105.